Core Insights - The company anticipates a revenue profile more weighted towards the first half of the fiscal year, driven by strong demand in January for health and fitness products [1] Financial Performance - Gross profit and adjusted EBITDA both increased by 56%, with adjusted EBITDA at £21.5 million and a margin of 28.9%, consistent with performance since the IPO [2] - Group revenue rose 57% year over year to £74.5 million, which is 24% higher than the second half of FY2025 [3][7] - Earnings per share were reported at 6.2p, and net cash at the end of the period was £26.4 million [2][7] Growth Drivers - Management highlighted broad-based channel growth, expanded international reach, and a focus on new product development as key growth drivers [4] - The company reported strong growth across all geographies, with notable performance in the UK, Europe, and Latin America, where sales rose 110% compared to the first half of FY2025 [8] Investment and Expansion Plans - Construction has begun on a global distribution facility with a fit-out cost of £3.5–4 million and a phase-3 production expansion costing approximately £2 million, aimed at increasing capacity to around £300 million [6][12][13] - Total capital expenditure is revised to approximately £5.5 million to £6 million, with spending expected to be weighted towards the second half of the year [14] Product Development and Market Strategy - The company is focusing on a wider health-conscious consumer base, with new product listings in mainstream retailers like Tesco [16] - Innovation is emphasized as a core strategy, with plans to refresh existing products and introduce new formats targeting emerging trends [20] Challenges and Mitigation - The company is monitoring shipping disruptions due to the evolving situation in the Middle East but maintains its full-year revenue guidance of £140 million [5][21] - Input costs, particularly for whey, have been under pressure, but the company plans a small price increase effective April 5 [23]